Consistently, other experimental works have provided evidence supporting the notion that the NRF2-dependent modulation of HIF-1α downstream signaling might represent a conserved mechanism through which breast cancer cells undergo metabolic adaptation and reprogramming [48,49]. Here, NFE2L2 is linked to breast cancer.